Skip to content
Screener

Veradermics MANE Accounts Payable

Accounts Payable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$9.22B-2.5%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$501.3M+377%
Organon logo
OrganonOGN
$983M-2.3%
PVL
Palvella TherapeuticsPVLA
$5.44M+22.6%
PTH
Pelthos TherapeuticsPTHS
$6.15M+136%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$2.83M+3.3%

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.78B+280%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Veradermics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 5:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001827635-26-000019

FAQ

What is Veradermics's accounts payable?
Veradermics (MANE) reported accounts payable of $1.07M in Q1 2026.
How has Veradermics's accounts payable changed year-over-year?
Veradermics's accounts payable increased by 256.1% year-over-year, from -$686K to $1.07M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Veradermics's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude